proteomics-keys-promise-of-predictive-medicine 
PharmExec
AUGUST 10, 2022
Major stakeholders—including policymakers, public-private interests, and academia—are increasingly embracing the potential of proteomics technology in reshaping diagnostics and patient care.
pharmaphorum
JANUARY 26, 2023
A 2022 study from the Royal College of Physicians and British Pharmacological Society demonstrated the potential of pharmacogenomics, with scientists identifying the genetic cause behind an individual’s drug response for over forty medicines. 2022 was a banner year for genomics.
Expert insights. Personalized for you.
59 
Let's personalize your content